Article Text

Download PDFPDF
General medicine
Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy

Statistics from


  • Contributors JSV wrote the initial draft. JST and FW made contributions to the draft. All authors approved the final manuscript.

  • Competing interests Carl Zeiss has sponsored some travel to some conferences and has paid some honoraria.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.